Alerts will be sent to your verified email
Verify EmailINDSWFTLAB
Ind-Swift Lab.
|
Themis Medicare
|
Unichem Lab
|
|
---|---|---|---|
Operational Metrics
|
|||
API Sector
|
|||
Total reactor capacity
|
700.0 kL | n/a | n/a |
DMF Filingsby API
|
474.0 . | n/a | n/a |
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
3.87 % | 2.68 % | 0.94 % |
Financials
|
|||
5 yr Average ROE
|
1.54 % | 13.04 % | -1.8 % |
5yr average Equity Multiplier
|
2.88 | 1.72 | 1.25 |
5yr Average Asset Turnover Ratio
|
0.52 | 0.67 | 0.39 |
5yr Avg Net Profit Margin
|
0.9 % | 11.29 % | -3.43 % |
Price to Book
|
0.94 | 5.46 | 1.76 |
P/E
|
15.48 | 43.87 | 290.43 |
5yr Avg Cash Conversion Cycle
|
169.25 Days | 62.75 Days | 134.58 Days |
Inventory Days
|
144.46 Days | 82.4 Days | 136.89 Days |
Days Receivable
|
144.51 Days | 126.49 Days | 147.31 Days |
Days Payable
|
91.2 Days | 162.52 Days | 232.31 Days |
5yr Average Interest Coverage Ratio
|
1.32 | 5.22 | -1.13 |
5yr Avg ROCE
|
8.03 % | 16.01 % | -1.02 % |
5yr Avg Operating Profit Margin
|
22.42 % | 18.66 % | 5.06 % |
5 yr average Debt to Equity
|
1.6 | 0.4 | 0.09 |
5yr CAGR Net Profit
|
10.46 % | n/a | 53.41 % |
5yr Average Return on Assets
|
0.55 % | 8.13 % | -1.39 % |
Shareholdings
|
|||
Promoter Holding
|
42.0 % | 67.15 % | 70.22 % |
Share Pledged by Promoters
|
48.57 % | 2.43 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.11 % | 19.29 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 1.59 % |
Ind-Swift Lab.
|
Themis Medicare
|
Unichem Lab
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|